Although gains have been made in achieving the health-related Millennium Development Goals (MDG), much is still needed in countries affected by high levels of HIV/AIDS. Prevention of mother-to-child transmission (PMTCT) is a cornerstone strategy in reducing infant mortality from HIV. The study will employ a cluster randomized control trial (cRCT) with 26 health facilities randomized to two arms (intervention or control) to determine the effect of mobile phone technology on completion of key PMTCT milestones from antenatal to six weeks postpartum. The study will examine the acceptability, effectiveness, and cost of implementing a PMTCT-focused mHealth strategy among HIV-infected pregnant women, health workers, and male partners.
Study Type
OBSERVATIONAL
Enrollment
600
Health facilities where PMTCT services are available in the traditional clinical setting with HIV testing and counseling, PMTCT support, and enrollment in care and treatment.
In addition to the 'Standard of Care', HIV-infected pregnant women and male partners within the PMTCT program are engaged in multi-directional mobile communication for PMTCT promotion with health care providers.
Elizabeth Glaser Pediatric AIDS Foundation
Nairobi, Kenya
The proportion of women who successfully complete key PMTCT transition points from antenatal to six weeks postpartum.
Time frame: ~ 6 months
Initiation of Infant prophylaxis, Facility delivery and receipt of results of 6 weeks early infant diagnosis by DNA PCR
Time frame: ~ 6 months
Uptake ARV prophylaxis/ART during labor, delivery, and postpartum
Time frame: ~ 6 months
Self-reported maternal adherence to ARV prophylaxis/ART during pregnancy
Time frame: ~ 4 months
Time to initiation of ARV prophylaxis/ART uptake after initial identification of HIV seropositivity within ANC
Time frame: ~ 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.